Information

Related Research Units

Cardiology Research

Research Overview

Steven Colan's research focuses on the assessment of myocardial diseases through echocardiography and other noninvasive modalities. His principal interests include evaluation of left ventricular systolic and diastolic function, clinical aspects of cardiomyopathies, and myocardial performance in congenital and acquired heart disease. To that end, many of his laboratory and clinical research projects revolve around the development and validation of non-invasive diagnostic methodologies and instruments and on the implementation of computer-based computational techniques to the analysis of cardiac physiology.

 

Research Background

Steven Colan received his MD from Boston University School of Medicine. He completed an internship and residency at Massachusetts General Hospital and a fellowship at Boston Children's Hospital.

 

Publications

  1. Central arterial stiffness in young adults with perinatal HIV exposure & infection. AIDS. 2025 Jan 27. View Abstract
  2. Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease. N Engl J Med. 2024 Nov 18. View Abstract
  3. The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. 2024 Oct 25. View Abstract
  4. Carvedilol to Improve Cardiac Remodeling in Anthracycline-Exposed Childhood Cancer Survivors: Subgroup Analysis of COG ALTE1621. JACC CardioOncol. 2024 Oct; 6(5):791-793. View Abstract
  5. Interatrial Communications: Prevalence and Subtypes in 12,385 Newborns-a Copenhagen Baby Heart Study. Pediatr Cardiol. 2024 Jul 13. View Abstract
  6. Reply: Understanding of Aging Effects on the Clinical Course in Patients With Congenital Heart Disease. J Am Coll Cardiol. 2024 May 28; 83(21):e205-e206. View Abstract
  7. Guidelines for Performing a Comprehensive Pediatric Transthoracic Echocardiogram: Recommendations From the American Society of Echocardiography. J Am Soc Echocardiogr. 2024 Feb; 37(2):119-170. View Abstract
  8. Abnormal Myocardial Deformation Despite Normal Ejection Fraction in Hutchinson-Gilford Progeria Syndrome. J Am Heart Assoc. 2024 Feb 06; 13(3):e031470. View Abstract
  9. Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry. J Am Heart Assoc. 2024 Jan 16; 13(2):e022557. View Abstract
  10. Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial. Lancet Oncol. 2024 Feb; 25(2):235-245. View Abstract
  11. Prognostic utility of a risk prediction model for predischarge major residual lesions or unplanned reinterventions following congenital mitral valve repair. J Thorac Cardiovasc Surg. 2024 Oct; 168(4):1192-1202.e8. View Abstract
  12. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. Cochrane Database Syst Rev. 2023 11 17; 11:CD011626. View Abstract
  13. Growth of the Neo-Aortic Root and Prognosis of Transposition of the Great Arteries. J Am Coll Cardiol. 2024 01 30; 83(4):516-527. View Abstract
  14. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1083-1088. View Abstract
  15. Survivors of Pediatric Hematopoietic Stem Cell Transplantation Exhibit Progressive Diastolic Dysfunction Over Years of Follow-Up. Transplant Cell Ther. 2023 Dec; 29(12):774.e1-774.e8. View Abstract
  16. Echocardiographic image collection and evaluation in infants with CHD: lessons learned from the imaging core lab for the Residual Lesion Score study. Cardiol Young. 2024 Mar; 34(3):570-575. View Abstract
  17. Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy. Am Heart J. 2023 10; 264:153-162. View Abstract
  18. Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association. Circulation. 2023 07 11; 148(2):174-195. View Abstract
  19. Normative Echocardiographic Left Ventricular Parameters and Reference Intervals in Infants. J Am Coll Cardiol. 2023 06 06; 81(22):2175-2185. View Abstract
  20. Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines. Circ Genom Precis Med. 2023 08; 16(4):350-358. View Abstract
  21. Natural history of aortic root dilatation and pathologic aortic regurgitation in tetralogy of Fallot and its morphological variants. J Thorac Cardiovasc Surg. 2023 12; 166(6):1718-1728.e4. View Abstract
  22. Natural History of Truncal Root Dilatation and Truncal Valve Regurgitation in Truncus Arteriosus. Ann Thorac Surg. 2023 07; 116(1):78-84. View Abstract
  23. Relationship of Left Ventricular Mass to Lean Body Mass in the Obese Pediatric Population. Pediatr Cardiol. 2024 Mar; 45(3):640-647. View Abstract
  24. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 04 20; 41(12):2248-2257. View Abstract
  25. Development of the Residual Lesion Score for congenital heart surgery: the RAND Delphi methodology. Cardiol Young. 2023 Jun; 33(6):977-990. View Abstract
  26. A novel algorithm for classification of interatrial communications within the oval fossa in the newborn. Cardiol Young. 2023 Oct; 33(10):1942-1949. View Abstract
  27. Intraoperative Residual Lesion Score Predicts Predischarge Major Residual Lesions and Reinterventions Following Congenital Heart Surgery. J Am Coll Cardiol. 2022 09 20; 80(12):1202-1204. View Abstract
  28. Residual Lesion Severity Predicts Midterm Outcomes After Congenital Aortic Valve Repair. Ann Thorac Surg. 2023 01; 115(1):159-165. View Abstract
  29. Long-Term Outcomes of Patients Requiring Unplanned Repeated Interventions After Surgery for Congenital Heart Disease. J Am Coll Cardiol. 2022 06 28; 79(25):2489-2499. View Abstract
  30. Intraoperative Technical Performance Score Predicts Outcomes After Congenital Cardiac Surgery. Ann Thorac Surg. 2023 02; 115(2):471-477. View Abstract
  31. Comparison of Intraoperative and Discharge Residual Lesion Severity in Congenital Heart Surgery. Ann Thorac Surg. 2022 11; 114(5):1731-1737. View Abstract
  32. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2022 03 30; 29(4):678-686. View Abstract
  33. Variability in Longitudinal Early Diastolic Strain Rate in Children: Authors' Reply. J Am Soc Echocardiogr. 2022 07; 35(7):786-788. View Abstract
  34. Matching Donor and Recipient Size in Pediatric Heart Transplantation. Transpl Int. 2022; 35:10226. View Abstract
  35. Assessment of Exercise Function in Children and Young Adults with Hypertrophic Cardiomyopathy and Correlation with Transthoracic Echocardiographic Parameters. Pediatr Cardiol. 2022 Jun; 43(5):1037-1045. View Abstract
  36. The genetic architecture of pediatric cardiomyopathy. Am J Hum Genet. 2022 02 03; 109(2):282-298. View Abstract
  37. Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med. 2021 10; 27(10):1818-1824. View Abstract
  38. Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort. Cardiol Young. 2022 Mar; 32(3):364-373. View Abstract
  39. Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles. Pediatr Res. 2022 07; 92(1):206-215. View Abstract
  40. Normal Left Ventricular Systolic and Diastolic Strain Rate Values in Children Derived from Two-Dimensional Speckle-Tracking Echocardiography. J Am Soc Echocardiogr. 2021 12; 34(12):1303-1315.e3. View Abstract
  41. Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11). World J Pediatr Congenit Heart Surg. 2021 09; 12(5):E1-E18. View Abstract
  42. Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11). Cardiol Young. 2021 Jul; 31(7):1057-1188. View Abstract
  43. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J. 2021 05 21; 42(20):1988-1996. View Abstract
  44. Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease. J Am Coll Cardiol. 2021 05 18; 77(19):2382-2394. View Abstract
  45. Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study. J Am Heart Assoc. 2021 05 04; 10(9):e017731. View Abstract
  46. Height Versus Body Surface Area to Normalize Cardiovascular Measurements in Children Using the Pediatric Heart Network Echocardiographic Z-Score Database. Pediatr Cardiol. 2021 Aug; 42(6):1284-1292. View Abstract
  47. Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation. Genet Med. 2021 07; 23(7):1281-1287. View Abstract
  48. Myocardial fibrosis in patients with a history of Kawasaki disease. Int J Cardiol Heart Vasc. 2021 Feb; 32:100713. View Abstract
  49. Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta. Am J Cardiol. 2021 04 01; 144:111-117. View Abstract
  50. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy. Circ Genom Precis Med. 2021 02; 14(1):e003062. View Abstract
  51. Pediatric Heart Network Echocardiographic Z Scores: Comparison with Other Published Models. J Am Soc Echocardiogr. 2021 02; 34(2):185-192. View Abstract
  52. Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions. Genet Med. 2021 01; 23(1):69-79. View Abstract
  53. Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy. Circ Genom Precis Med. 2020 10; 13(5):396-405. View Abstract
  54. Longitudinal Variation in Presence and Severity of Cardiac Valve Regurgitation in Healthy Children. J Am Soc Echocardiogr. 2020 11; 33(11):1400-1406. View Abstract
  55. Technical Performance Score's Association With Arterial Switch Operation Outcomes. Ann Thorac Surg. 2021 04; 111(4):1367-1373. View Abstract
  56. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738. View Abstract
  57. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Circulation. 2020 07 21; 142(3):217-229. View Abstract
  58. Value of Exercise Stress Echocardiography in Children with Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2020 07; 33(7):888-894.e2. View Abstract
  59. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry. Circulation. 2020 04 28; 141(17):1371-1383. View Abstract
  60. Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39(4S):S457. View Abstract
  61. Challenges and lessons learned from the Pediatric Heart Network Normal Echocardiogram Database study. Cardiol Young. 2020 Apr; 30(4):456-461. View Abstract
  62. Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy. AIDS. 2020 03 15; 34(4):529-537. View Abstract
  63. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy. Circulation. 2020 03 10; 141(10):828-842. View Abstract
  64. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2020 01 01; 5(1):83-91. View Abstract
  65. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy. JAMA Cardiol. 2020 01 01; 5(1):65-72. View Abstract
  66. Baseline Characteristics of the VANISH Cohort. Circ Heart Fail. 2019 12; 12(12):e006231. View Abstract
  67. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors. Cardiooncology. 2019; 5:18. View Abstract
  68. The Pediatric Heart Network Residual Lesion Score Study: Design and objectives. J Thorac Cardiovasc Surg. 2020 07; 160(1):218-223.e1. View Abstract
  69. Comparison of echocardiographic measurements to invasive measurements of diastolic function in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial. Cardiol Young. 2019 Oct; 29(10):1248-1256. View Abstract
  70. Challenges With Left Ventricular Functional Parameters: The Pediatric Heart Network Normal Echocardiogram Database. J Am Soc Echocardiogr. 2019 10; 32(10):1331-1338.e1. View Abstract
  71. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543. View Abstract
  72. How Well Does the Neonatal Heart Measure Up? J Am Soc Echocardiogr. 2019 07; 32(7):906-908. View Abstract
  73. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation. 2019 07 02; 140(1):e9-e68. View Abstract
  74. Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)". Circulation. 2019 03 19; 139(12):1559-1560. View Abstract
  75. Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry. Prog Pediatr Cardiol. 2019 Jun; 53:1-10. View Abstract
  76. Normal Values for Left Ventricular Strain and Synchrony in Children Based on Speckle Tracking Echocardiography. Am J Cardiol. 2019 05 01; 123(9):1546-1554. View Abstract
  77. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy. Genome Med. 2019 01 29; 11(1):5. View Abstract
  78. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. Radiology. 2019 03; 290(3):640-648. View Abstract
  79. Characterization of Left Ventricular Dysfunction by Myocardial Strain in Critical Pulmonary Stenosis and Pulmonary Atresia After Neonatal Pulmonary Valve Balloon Dilation. Am J Cardiol. 2019 02 01; 123(3):454-459. View Abstract
  80. Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies. AIDS. 2018 10 23; 32(16):2337-2346. View Abstract
  81. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy. Circ Heart Fail. 2018 09; 11(9):e005191. View Abstract
  82. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation. 2018 10 02; 138(14):1387-1398. View Abstract
  83. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy. Circulation. 2018 08 21; 138(8):782-792. View Abstract
  84. Left Atrial Size and Function in Patients With Congenital Aortic Valve Stenosis. Am J Cardiol. 2018 11 01; 122(9):1541-1545. View Abstract
  85. Long-Term Outcomes of Childhood Left Ventricular Noncompaction Cardiomyopathy: Results From a National Population-Based Study. Circulation. 2018 07 24; 138(4):367-376. View Abstract
  86. Classification of Ventricular Septal Defects for the Eleventh Iteration of the International Classification of Diseases-Striving for Consensus: A Report From the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann Thorac Surg. 2018 11; 106(5):1578-1589. View Abstract
  87. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. Cochrane Database Syst Rev. 2018 07 12; 7:CD011626. View Abstract
  88. Impact of Ventricular Morphology on Fiber Stress and Strain in Fontan Patients. Circ Cardiovasc Imaging. 2018 07; 11(7):e006738. View Abstract
  89. Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children. AIDS. 2018 06 19; 32(10):1267-1277. View Abstract
  90. Normal Values and Growth-Related Changes of Left Ventricular Volumes, Stress, and Strain in Healthy Children Measured by 3-Dimensional Echocardiography. Am J Cardiol. 2018 07 15; 122(2):331-339. View Abstract
  91. Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis. J Pediatr. 2018 07; 198:29-35.e5. View Abstract
  92. Longitudinal Assessment of the Doppler-Estimated Maximum Gradient in Patients With Congenital Valvar Aortic Stenosis Pre- and Post-Balloon Valvuloplasty. Circ Cardiovasc Imaging. 2018 03; 11(3):e006708. View Abstract
  93. Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study. Circulation. 2018 07 03; 138(1):29-36. View Abstract
  94. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome. Am J Cardiol. 2018 05 01; 121(9):1094-1101. View Abstract
  95. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail. 2018 03; 6(3):222-230. View Abstract
  96. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. J Cardiovasc Magn Reson. 2017 12 28; 19(1):107. View Abstract
  97. Technical Performance Score Predicts Partial/Transitional Atrioventricular Septal Defect Outcomes. Ann Thorac Surg. 2018 05; 105(5):1461-1468. View Abstract
  98. Left Atrial Volumes and Strain in Healthy Children Measured by Three-Dimensional Echocardiography: Normal Values and Maturational Changes. J Am Soc Echocardiogr. 2018 02; 31(2):187-193.e1. View Abstract
  99. Nomenclature for congenital and paediatric cardiac disease: the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11). Cardiol Young. 2017 Dec; 27(10):1872-1938. View Abstract
  100. Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. J Am Coll Cardiol. 2017 Nov 28; 70(21):2663-2673. View Abstract
  101. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart. 2017; 4(2):e000615. View Abstract
  102. Reproducibility of Left Ventricular Dimension Versus Area Versus Volume Measurements in Pediatric Patients With Dilated Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Nov; 10(11). View Abstract
  103. Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity: The Pediatric Heart Network Normal Echocardiogram Database. Circ Cardiovasc Imaging. 2017 Nov; 10(11). View Abstract
  104. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study. J Am Coll Cardiol. 2017 Oct 31; 70(18):2240-2247. View Abstract
  105. Pediatric Cardiomyopathies. Circ Res. 2017 Sep 15; 121(7):855-873. View Abstract
  106. 2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2017 08; 10(8). View Abstract
  107. 2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2017 08 22; 70(8):1029-1095. View Abstract
  108. Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure. J Am Coll Cardiol. 2017 Jun 06; 69(22):2735-2744. View Abstract
  109. The Effect of the Superior Cavopulmonary Anastomosis on Ventricular Remodeling in Infants with Single Ventricle. J Am Soc Echocardiogr. 2017 Jul; 30(7):699-707.e1. View Abstract
  110. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017 04 01; 2(4):419-428. View Abstract
  111. The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. Am Heart J. 2017 May; 187:145-155. View Abstract
  112. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail. 2017 Feb; 10(2). View Abstract
  113. Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. J Thorac Cardiovasc Surg. 2017 03; 153(3):638-645.e2. View Abstract
  114. Implementation of a Quality Improvement Bundle Improves Echocardiographic Imaging after Congenital Heart Surgery in Children. J Am Soc Echocardiogr. 2016 12; 29(12):1163-1170.e3. View Abstract
  115. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure. BMC Cardiovasc Disord. 2016 10 04; 16(1):187. View Abstract
  116. Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery. Pediatr Crit Care Med. 2016 10; 17(10):939-947. View Abstract
  117. Relation of Left Atrial Size to Atrial Fibrillation in Patients Aged =22 Years. Am J Cardiol. 2017 Jan 01; 119(1):52-56. View Abstract
  118. Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure. J Am Soc Echocardiogr. 2016 11; 29(11):1066-1073. View Abstract
  119. Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers. Heart. 2016 Nov 15; 102(22):1805-1812. View Abstract
  120. Progressive intermediate-term improvement in ventricular and atrioventricular interaction after transcatheter pulmonary valve replacement in patients with right ventricular outflow tract obstruction. Am Heart J. 2016 09; 179:87-98. View Abstract
  121. Technical Performance Score Predicts Resource Utilization in Congenital Cardiac Procedures. J Am Coll Cardiol. 2016 06 07; 67(22):2696-8. View Abstract
  122. Multidimensional structure-function relationships in human ß-cardiac myosin from population-scale genetic variation. Proc Natl Acad Sci U S A. 2016 06 14; 113(24):6701-6. View Abstract
  123. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth. AIDS Res Hum Retroviruses. 2016 07; 32(7):621-7. View Abstract
  124. Effects of commonly used inotropes on myocardial function and oxygen consumption under constant ventricular loading conditions. J Appl Physiol (1985). 2016 07 01; 121(1):7-14. View Abstract
  125. Aortic Stiffness in Youth with Hypertrophic Cardiomyopathy Genotype. Pediatr Cardiol. 2016 Jun; 37(5):932-7. View Abstract
  126. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. J Appl Physiol (1985). 2016 Jun 01; 120(11):1301-18. View Abstract
  127. Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy. J Pediatr. 2016 Mar; 170:173-80.e1-4. View Abstract
  128. Correction of Doppler Gradients for Pressure Recovery Improves Agreement with Subsequent Catheterization Gradients in Congenital Aortic Stenosis. J Am Soc Echocardiogr. 2015 Dec; 28(12):1410-7. View Abstract
  129. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr. 2016 Feb; 29(2):150-7. View Abstract
  130. Impact of Variability in Echocardiographic Interpretation on Assessment of Adequacy of Repair Following Congenital Heart Surgery: A Pilot Study. Pediatr Cardiol. 2016 Jan; 37(1):144-50. View Abstract
  131. Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children's Heart Institute. Cardiol Young. 2015 Aug; 25 Suppl 2:8-30. View Abstract
  132. Review of the International Society for Heart and Lung Transplantation Practice guidelines for management of heart failure in children. Cardiol Young. 2015 Aug; 25 Suppl 2:154-9. View Abstract
  133. Left Ventricular Strain and Myocardial Fibrosis in Congenital Aortic Stenosis. Am J Cardiol. 2015 Oct 15; 116(8):1257-62. View Abstract
  134. Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Pediatr Nephrol. 2015 Dec; 30(12):2177-88. View Abstract
  135. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015 Nov; 21(11):877-84. View Abstract
  136. Fontan physiology revisited. Anesth Analg. 2015 Jul; 121(1):172-182. View Abstract
  137. Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. J Am Coll Cardiol. 2015 Jun 02; 65(21):2302-10. View Abstract
  138. Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease. Clin Nephrol. 2015 May; 83(5):262-71. View Abstract
  139. Left Ventricular Dysfunction Following Neonatal Pulmonary Valve Balloon Dilation for Pulmonary Atresia or Critical Pulmonary Stenosis. Pediatr Cardiol. 2015 Aug; 36(6):1186-93. View Abstract
  140. The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent. J Am Soc Echocardiogr. 2015 May; 28(5):549-558.e1. View Abstract
  141. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. AIDS. 2015 Jan 02; 29(1):91-100. View Abstract
  142. Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med. 2015; 66:161-76. View Abstract
  143. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial. BMJ Open. 2014 Dec 08; 4(12):e005360. View Abstract
  144. Carotid artery intima-media thickness measurements in the youth: reproducibility and technical considerations. J Am Soc Echocardiogr. 2015 Mar; 28(3):309-16. View Abstract
  145. Adrenergic receptor genotype influences heart failure severity and ß-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015 Feb; 77(2):363-9. View Abstract
  146. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27; 371(22):2061-71. View Abstract
  147. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. JACC Heart Fail. 2015 Feb; 3(2):180-8. View Abstract
  148. Outcomes differ in patients who undergo immediate intraoperative revision versus patients with delayed postoperative revision of residual lesions in congenital heart operations. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2540-6.e1-5. View Abstract
  149. Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc. 2014 Jun 23; 3(3):e000079. View Abstract
  150. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2208-13, 2214.e1-6. View Abstract
  151. Survival data and predictors of functional outcome an average of 15?years after the Fontan procedure: the pediatric heart network Fontan cohort. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E30-42. View Abstract
  152. Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014). Ecancermedicalscience. 2014; 8:433. View Abstract
  153. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014 May 06; 63(17):1778-85. View Abstract
  154. Mixed aortic valve disease in the young: initial observations. Pediatr Cardiol. 2014 Aug; 35(6):934-42. View Abstract
  155. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2014 Apr 15; 63(14):1405-13. View Abstract
  156. Factors associated with serum B-type natriuretic peptide in infants with single ventricles. Pediatr Cardiol. 2014 Jun; 35(5):879-87. View Abstract
  157. A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy. PLoS Curr. 2013 Dec 12; 5. View Abstract
  158. The relationship of patient medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure. Pediatr Cardiol. 2014 Apr; 35(4):632-40. View Abstract
  159. Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol. 2014 Apr; 35(4):658-67. View Abstract
  160. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013 Nov; 6(6):1214-22. View Abstract
  161. Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging. 2013 Nov; 6(6):934-42. View Abstract
  162. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013 Oct 22; 128(17):1927-95. View Abstract
  163. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation. 2013 Oct 29; 128(18):2039-46. View Abstract
  164. Technical Performance Scores are strongly associated with early mortality, postoperative adverse events, and intensive care unit length of stay-analysis of consecutive discharges for 2 years. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):389-94, 396.e1-396.e3. View Abstract
  165. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet. 2013 Dec 07; 382(9908):1889-97. View Abstract
  166. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33. View Abstract
  167. Heterogeneity of regional function and relation to ventricular morphology in patients with fontan circulation. Am J Cardiol. 2013 Oct 15; 112(8):1207-13. View Abstract
  168. Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer. 2013 Oct 01; 119(19):3555-62. View Abstract
  169. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013 Sep 17; 62(12):1114-1121. View Abstract
  170. Inadequate technical performance scores are associated with late mortality and late reintervention. Ann Thorac Surg. 2013 Aug; 96(2):664-9. View Abstract
  171. Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta. Congenit Heart Dis. 2014 May-Jun; 9(3):235-43. View Abstract
  172. Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. JAMA Pediatr. 2013 Jun; 167(6):520-7. View Abstract
  173. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet. 2013 Jun; 6(3):230-7. View Abstract
  174. Factors impacting echocardiographic imaging after the Fontan procedure: a report from the pediatric heart network fontan cross-sectional study. Echocardiography. 2013 Oct; 30(9):1098-106. View Abstract
  175. Cardiac biomarkers in HIV-exposed uninfected children. AIDS. 2013 Apr 24; 27(7):1099-108. View Abstract
  176. Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome. J Am Soc Echocardiogr. 2013 Jun; 26(6):657-66. View Abstract
  177. Doppler flow patterns in the right ventricle-to-pulmonary artery shunt and neo-aorta in infants with single right ventricle anomalies: impact on outcome after initial staged palliations. J Am Soc Echocardiogr. 2013 May; 26(5):521-9. View Abstract
  178. Ventricular mechanics in patients with aortic valve disease: longitudinal, radial, and circumferential components. Cardiol Young. 2014 Feb; 24(1):105-12. View Abstract
  179. Coronary artery dimensions in febrile children without Kawasaki disease. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):239-44. View Abstract
  180. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A. 2013 Jan 22; 110(4):1446-51. View Abstract
  181. The why and how of Z scores. J Am Soc Echocardiogr. 2013 Jan; 26(1):38-40. View Abstract
  182. Limitations of expressing left ventricular mass relative to height and to body surface area in children. J Am Soc Echocardiogr. 2013 Apr; 26(4):410-8. View Abstract
  183. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15; 380(9859):2095-128. View Abstract
  184. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15; 380(9859):2163-96. View Abstract
  185. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15; 380(9859):2197-223. View Abstract
  186. Correlation of exercise response in repaired coarctation of the aorta to left ventricular mass and geometry. Am J Cardiol. 2013 Feb 01; 111(3):406-11. View Abstract
  187. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics. 2012 Dec; 130(6):1003-11. View Abstract
  188. A shifting approach to management of the thoracic aorta in bicuspid aortic valve. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):339-46. View Abstract
  189. Left ventricular diastolic function in children and young adults with congenital aortic valve disease. Am J Cardiol. 2013 Jan 15; 111(2):243-9. View Abstract
  190. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS. 2012 Oct 23; 26(16):2027-37. View Abstract
  191. Echocardiographic predictors of left ventricular dysfunction after aortic valve surgery in children with chronic aortic regurgitation. Congenit Heart Dis. 2013 Jul-Aug; 8(4):308-15. View Abstract
  192. Genetic variations in hypoxia response genes influence hypertrophic cardiomyopathy phenotype. Pediatr Res. 2012 Dec; 72(6):583-92. View Abstract
  193. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64. View Abstract
  194. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ Cardiovasc Genet. 2012 Oct 01; 5(5):503-10. View Abstract
  195. Surgical technical performance scores are predictors of late mortality and unplanned reinterventions in infants after cardiac surgery. J Thorac Cardiovasc Surg. 2012 Nov; 144(5):1095-1101.e7. View Abstract
  196. Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle. J Thorac Cardiovasc Surg. 2013 May; 145(5):1288-96. View Abstract
  197. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2012 Sep; 164(3):442-8. View Abstract
  198. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012 Sep 04; 126(10):1237-44. View Abstract
  199. Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection. Cardiol Young. 2013 Jun; 23(3):335-43. View Abstract
  200. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012 Aug 28; 126(9):1079-86. View Abstract
  201. Technical performance scores in congenital cardiac operations: a quality assessment initiative. Ann Thorac Surg. 2012 Oct; 94(4):1317-23; discussion 1323. View Abstract
  202. Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Congenit Heart Dis. 2013 Jan-Feb; 8(1):32-9. View Abstract
  203. Bicuspid aortic valve and associated aortic dilation in the young. Heart. 2012 Jul; 98(13):1014-9. View Abstract
  204. Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis. Circ Cardiovasc Interv. 2012 Aug 01; 5(4):549-54. View Abstract
  205. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012 Aug; 25(8):842-854.e6. View Abstract
  206. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail. 2012 Jul 01; 5(4):462-6. View Abstract
  207. Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy?: the Single Vventricle Reconstruction trial. Circulation. 2012 May 29; 125(21):2630-8. View Abstract
  208. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 2012 Apr 01; 30(10):1042-9. View Abstract
  209. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol. 2012 Feb 07; 59(6):607-15. View Abstract
  210. Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant. 2012 May; 31(5):517-23. View Abstract
  211. Changes in left atrioventricular valve geometry after surgical repair of complete atrioventricular canal. J Thorac Cardiovasc Surg. 2012 May; 143(5):1117-24. View Abstract
  212. A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children. Congenit Heart Dis. 2011 Nov-Dec; 6(6):608-23. View Abstract
  213. Non-geometric echocardiographic indices of ventricular function in patients with a Fontan circulation. J Am Soc Echocardiogr. 2011 Nov; 24(11):1213-9. View Abstract
  214. Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr. 2012 Feb; 25(2):194-202. View Abstract
  215. Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs). Congenit Heart Dis. 2011 Nov-Dec; 6(6):558-65. View Abstract
  216. Donald Charles Fyler: 1924–2011. Cardiol Young. 2011 Oct; 21(5):485-9. View Abstract
  217. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol. 2011 Dec 01; 108(11):1606-13. View Abstract
  218. Challenges in echocardiographic assessment of mitral regurgitation in children after repair of atrioventricular septal defect. Pediatr Cardiol. 2012 Feb; 33(2):205-14. View Abstract
  219. Surgical interventions for atrioventricular septal defect subtypes: the pediatric heart network experience. Ann Thorac Surg. 2011 Oct; 92(4):1468-75; discussion 1475. View Abstract
  220. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011 Aug 16; 124(7):814-23. View Abstract
  221. Coronary artery dilation in sickle cell disease. J Pediatr. 2011 Nov; 159(5):789-794.e1-2. View Abstract
  222. Impact of HFE mutations on cardiac status in survivors of childhood high-risk ALL: Dana-Farber Cancer Institute Childhood ALL 05-159. J Clin Oncol. 2011 May 20; 29(15_suppl):9508. View Abstract
  223. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation. 2011 May 31; 123(21):2353-62. View Abstract
  224. Factors associated with serum brain natriuretic peptide levels after the Fontan procedure. Congenit Heart Dis. 2011 Jul-Aug; 6(4):313-21. View Abstract
  225. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res. 2011 Mar 04; 108(5):619-28. View Abstract
  226. Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome. Am J Med Genet A. 2011 Mar; 155A(3):486-507. View Abstract
  227. Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 - Nomenclature of complications associated with interventional cardiology). Cardiol Young. 2011 Jun; 21(3):260-5. View Abstract
  228. Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 1 - Procedural nomenclature). Cardiol Young. 2011 Jun; 21(3):252-9. View Abstract
  229. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb; 161(2):233-40. View Abstract
  230. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant. 2011 Dec; 46(12):1532-9. View Abstract
  231. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol. 2011 Jan 04; 57(1):76-85. View Abstract
  232. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011 Jan 04; 57(1):86-92. View Abstract
  233. Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J. 2011 Jan; 161(1):13-67. View Abstract
  234. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr. 2011 Jan; 24(1):53-9. View Abstract
  235. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3. View Abstract
  236. Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1371-9. View Abstract
  237. Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol. 2010 Nov 30; 56(23):1939-46. View Abstract
  238. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010 Oct; 6(4):401-13, vii. View Abstract
  239. Hypertrophic cardiomyopathy in childhood. Heart Fail Clin. 2010 Oct; 6(4):433-44, vii-iii. View Abstract
  240. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J. 2010 Oct; 160(4):776-83. View Abstract
  241. Report from the international society for nomenclature of paediatric and congenital heart disease: creation of a visual encyclopedia illustrating the terms and definitions of the international pediatric and congenital cardiac code. World J Pediatr Congenit Heart Surg. 2010 Oct; 1(3):300-13. View Abstract
  242. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 2010 Oct; 11(10):950-61. View Abstract
  243. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010 Nov; 3(6):689-97. View Abstract
  244. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010 Aug 05; 363(6):552-63. View Abstract
  245. A novel approach to gathering and acting on relevant clinical information: SCAMPs. Congenit Heart Dis. 2010 Jul-Aug; 5(4):343-53. View Abstract
  246. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010 Jul-Aug; 5(4):374-81. View Abstract
  247. An echocardiographic model predicting severity of aortic regurgitation in congenital heart disease. Circ Cardiovasc Imaging. 2010 Sep; 3(5):542-9. View Abstract
  248. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010 May 27; 362(21):1980-92. View Abstract
  249. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010 May; 23(5):465-95; quiz 576-7. View Abstract
  250. Fetal diagnosis of interrupted aortic arch. Am J Cardiol. 2010 Mar 01; 105(5):727-34. View Abstract
  251. Partial and transitional atrioventricular septal defect outcomes. Ann Thorac Surg. 2010 Feb; 89(2):530-6. View Abstract
  252. Aortic translocation for the management of double-outlet right ventricle and pulmonary stenosis with dextrocardia: technique to avoid coronary insufficiency. Ann Thorac Surg. 2010 Feb; 89(2):633-5. View Abstract
  253. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol. 2010 Jan 26; 55(4):320-9. View Abstract
  254. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010 Jan 05; 121(1):34-42. View Abstract
  255. Diastolic function in children with Kawasaki disease. Int J Cardiol. 2011 May 05; 148(3):309-12. View Abstract
  256. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009 Nov; 2(6):591-8. View Abstract
  257. Functional state following the Fontan procedure. Cardiol Young. 2009 Aug; 19(4):320-30. View Abstract
  258. Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol. 2009 Aug 01; 104(3):419-28. View Abstract
  259. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009 Jul 15; 104(2):281-6. View Abstract
  260. Gender differences in long-term dexrazoxane cardioprotection in doxorubicin-treated children with acute lymphoblastic leukemia. J Clin Oncol. 2009 May 20; 27(15_suppl):10005. View Abstract
  261. Clinical Issues in the Pediatric Hypertrophic Cardiomyopathies. Prog Pediatr Cardiol. 2009 Apr 01; 25(1):27-29. View Abstract
  262. Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium. J Thorac Cardiovasc Surg. 2009 Jun; 137(6):1356-62, 1362.e1-3. View Abstract
  263. Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr. 2009 Jun; 154(6):901-5. View Abstract
  264. Nomenclature and databases for the surgical treatment of congenital cardiac disease--an updated primer and an analysis of opportunities for improvement. Cardiol Young. 2008 Dec; 18 Suppl 2:38-62. View Abstract
  265. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young. 2008 Dec; 18 Suppl 2:70-80. View Abstract
  266. Cardiac complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008 Dec; 18 Suppl 2:196-201. View Abstract
  267. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging. 2008 Sep; 1(5):572-8. View Abstract
  268. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol. 2009 Apr; 30(3):306-10. View Abstract
  269. Measurement of technical performance in surgery for congenital heart disease: the stage I Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):993-7, 997.e1-2. View Abstract
  270. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008 Jul 08; 52(2):85-98. View Abstract
  271. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008 Jul 08; 52(2):99-107. View Abstract
  272. Echocardiographic predictors of mitral stenosis-related death or intervention in infants. Am Heart J. 2008 Aug; 156(2):384-90. View Abstract
  273. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics. 2008 Jun; 121(6):e1622-7. View Abstract
  274. A novel method of expressing left ventricular mass relative to body size in children. Circulation. 2008 May 27; 117(21):2769-75. View Abstract
  275. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):968-75. View Abstract
  276. Idiopathic and Primary Cardiomyopathies in Children. Prog Pediatr Cardiol. 2008 Apr; 25(1):1. View Abstract
  277. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008 Jun; 155(6):998-1005. View Abstract
  278. Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: acute and intermediate effects on aortic valve function and left ventricular dimensions. J Thorac Cardiovasc Surg. 2008 Mar; 135(3):552-9, 559.e1-3. View Abstract
  279. Clinical utility of Doppler echocardiography in assessing aortic stenosis severity and predicting need for intervention in children. Pediatr Cardiol. 2008 May; 29(3):507-14. View Abstract
  280. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40. View Abstract
  281. Cardiac magnetic resonance versus routine cardiac catheterization before bidirectional glenn anastomosis in infants with functional single ventricle: a prospective randomized trial. Circulation. 2007 Dec 04; 116(23):2718-25. View Abstract
  282. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007 Oct; 154(4):624-31. View Abstract
  283. Changes in left heart hemodynamics after technically successful in-utero aortic valvuloplasty. Ultrasound Obstet Gynecol. 2007 Oct; 30(5):715-20. View Abstract
  284. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol. 2008 Mar; 29(2):343-51. View Abstract
  285. The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy. Cardiol Young. 2007 Sep; 17 Suppl 2:1-28. View Abstract
  286. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007 Jul 10; 116(2):174-9. View Abstract
  287. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol. 2007 Jun 05; 49(22):2211-4. View Abstract
  288. Prospective assessment after pediatric cardiac ablation: fate of intracardiac structure and function, as assessed by serial echocardiography. Am Heart J. 2007 May; 153(5):815-20, 820.e1-6. View Abstract
  289. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75. View Abstract
  290. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007 Feb 13; 115(6):773-81. View Abstract
  291. Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg. 2007 Jan; 83(1):179-84. View Abstract
  292. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006 Dec 12; 114(24):2671-8. View Abstract
  293. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006 Oct 18; 296(15):1867-76. View Abstract
  294. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics. 2006 Oct; 118(4):1519-31. View Abstract
  295. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006 Sep; 152(3):427-33. View Abstract
  296. The nomenclature, definition and classification of discordant atrioventricular connections. Cardiol Young. 2006 Sep; 16 Suppl 3:72-84. View Abstract
  297. The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity. Leuk Lymphoma. 2006 Aug; 47(8):1454-8. View Abstract
  298. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics. 2006 Aug; 118(2):e415-20. View Abstract
  299. The nomenclature, definition and classification of hypoplastic left heart syndrome. Cardiol Young. 2006 Aug; 16(4):339-68. View Abstract
  300. Cardiac and clinical phenotype in Barth syndrome. Pediatrics. 2006 Aug; 118(2):e337-46. View Abstract
  301. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol. 2006 May-Jun; 27(3):336-42. View Abstract
  302. Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis. J Am Coll Cardiol. 2006 May 02; 47(9):1858-65. View Abstract
  303. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation. 2006 Mar 21; 113(11):1401-5. View Abstract
  304. Classification of the functionally univentricular heart: unity from mapped codes. Cardiol Young. 2006 Feb; 16 Suppl 1:9-21. View Abstract
  305. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs. Circulation. 2005 Nov 01; 112(18):2756-8. View Abstract
  306. Midwall shortening after coarctation repair: the effect of through-plane motion on single-plane indices of left ventricular function. J Am Soc Echocardiogr. 2005 Nov; 18(11):1131-6. View Abstract
  307. ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation. 2005 Oct 18; 112(16):2555-80. View Abstract
  308. ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics. 2005 Dec; 116(6):1574-96. View Abstract
  309. ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 2: pediatric training guidelines for noninvasive cardiac imaging endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography. J Am Coll Cardiol. 2005 Oct 04; 46(7):1384-8. View Abstract
  310. Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. Am Heart J. 2005 Sep; 150(3):439-47. View Abstract
  311. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005 Aug 30; 112(9):1332-8. View Abstract
  312. Improving outcomes in fetuses and neonates with congenital displacement (Ebstein's malformation) or dysplasia of the tricuspid valve. Am J Cardiol. 2005 Aug 15; 96(4):582-6. View Abstract
  313. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics. 2005 Jun; 115(6):1613-22. View Abstract
  314. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005 Apr 20; 23(12):2629-36. View Abstract
  315. Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation. 2005 Feb 01; 111(4):451-8. View Abstract
  316. The current status and future directions of efforts to create a global database for the outcomes of therapy for congenital heart disease. Cardiol Young. 2005 Feb; 15 Suppl 1:190-7. View Abstract
  317. Accuracy of echocardiography in low birth weight infants with congenital heart disease. Pediatrics. 2005 Jan; 115(1):102-7. View Abstract
  318. Atrioventricular discordance with ventriculoarterial concordance: A remaining indication for the atrial switch operation. J Thorac Cardiovasc Surg. 2004 Dec; 128(6):944-5. View Abstract
  319. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004 Dec; 23(12):1313-33. View Abstract
  320. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol (1985). 2005 Aug; 99(2):445-57. View Abstract
  321. Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol. 2004 Oct 19; 44(8):1648-51. View Abstract
  322. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation. 2004 Oct 12; 110(15):2125-31. View Abstract
  323. Recombinant human growth hormone treatment for dilated cardiomyopathy in children. Pediatrics. 2004 Oct; 114(4):e452-8. View Abstract
  324. Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation. 2004 Sep 14; 110(11 Suppl 1):II128-32. View Abstract
  325. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004 Aug 01; 22(15):3139-48. View Abstract
  326. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004 Jul 21; 44(2):391-7. View Abstract
  327. Echocardiographic (Echo) monitoring of myocardial injury during doxorubicin (DOX) therapy for childhood acute lymphoblastic leukemia (ALL). J Clin Oncol. 2004 Jul 15; 22(14_suppl):8505. View Abstract
  328. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004 Jul 08; 351(2):145-53. View Abstract
  329. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol. 2004 Jul; 15(7):759-70. View Abstract
  330. Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. Heart Rhythm. 2004 Jul; 1(2):188-96. View Abstract
  331. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004 Jun 01; 93(11):1374-7, A6. View Abstract
  332. Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr. 2004 Apr; 144(4):444-8. View Abstract
  333. Update from the International Working Group for Mapping and Coding of Nomenclatures for Paediatric and Congenital Heart Disease. Cardiol Young. 2004 Apr; 14(2):225-9. View Abstract
  334. Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol. 2004 Mar 01; 22(5):769-73. View Abstract
  335. Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study. Pediatr Dev Pathol. 2004 Jan-Feb; 7(1):61-70. View Abstract
  336. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study. Cardiovasc Toxicol. 2004; 4(2):187-97. View Abstract
  337. Tissue velocity Doppler assessment of atrial and ventricular electromechanical coupling and atrioventricular time intervals in normal subjects. Am J Cardiol. 2003 Dec 01; 92(11):1347-50. View Abstract
  338. Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol. 2003 Sep 01; 92(5):636-9. View Abstract
  339. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics. 2003 Jul; 112(1 Pt 1):79-86. View Abstract
  340. Clinical outcomes and utility of cardiac catheterization prior to superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 2003 Jul; 126(1):272-81. View Abstract
  341. Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. Cardiovasc Pathol. 2003 May-Jun; 12(3):140-8. View Abstract
  342. Growth of the aorta in children with Williams syndrome: does surgery make a difference? Pediatr Cardiol. 2003 Nov-Dec; 24(6):566-8. View Abstract
  343. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003 Apr 24; 348(17):1647-55. View Abstract
  344. Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. Am Heart J. 2003 Apr; 145(4):716-23. View Abstract
  345. Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium. Herz. 2003 Feb; 28(1):52-62. View Abstract
  346. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002 Dec 01; 20(23):4517-22. View Abstract
  347. Echocardiographic assessment of the right ventricular response to hypertension in neonates on the basis of average-shaped contraction models. J Am Soc Echocardiogr. 2002 Oct; 15(10 Pt 2):1145-53. View Abstract
  348. Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. J Pediatr. 2002 Sep; 141(3):327-34. View Abstract
  349. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet. 2002 Aug 03; 360(9330):368-73. View Abstract
  350. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. J Clin Oncol. 2002 Mar 15; 20(6):1677-82. View Abstract
  351. Prospective assessment after pediatric cardiac ablation: design and implementation of the multicenter study. Pacing Clin Electrophysiol. 2002 Mar; 25(3):332-41. View Abstract
  352. Wall stress misrepresents afterload in children and young adults with abnormal left ventricular geometry. J Appl Physiol (1985). 2002 Mar; 92(3):1053-7. View Abstract
  353. Adaptive mechanisms of left ventricular diastolic function to the physiologic load of pregnancy. Clin Cardiol. 2002 Mar; 25(3):124-31. View Abstract
  354. Systolic and diastolic performance late after the Fontan procedure for a single ventricle and comparison of those undergoing operation at <12 months of age and at >12 months of age. Am J Cardiol. 2002 Feb 01; 89(3):276-80. View Abstract
  355. Re: Reduction in levels of triidothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome. Cardiol Young. 2002 Jan; 12(1):84-5. View Abstract
  356. Congestive heart failure in pediatric patients. Am Heart J. 2001 Nov; 142(5):923-8. View Abstract
  357. Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study. Circulation. 2001 Jul 17; 104(3):310-6. View Abstract
  358. Aortic root dilation in Kawasaki disease. Am J Cardiol. 2001 Apr 01; 87(7):919-22. View Abstract
  359. Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study. Am Heart J. 2001 Apr; 141(4):661-70. View Abstract
  360. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid. 2001 Mar; 11(3):281-91. View Abstract
  361. The risk of having additional obstructive lesions in neonatal coarctation of the aorta. Cardiol Young. 2001 Jan; 11(1):44-53. View Abstract
  362. Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol. 2001 Jan; 37(1):201-7. View Abstract
  363. Exogenous growth hormone: a new therapy for dilated cardiomyopathy. Prog Pediatr Cardiol. 2000 Nov 04; 12(1):125-132. View Abstract
  364. Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study. Am Heart J. 2000 Oct; 140(4):575-84. View Abstract
  365. Misrepresentation of left ventricular contractile function by endocardial indexes: clinical implications after coarctation repair. Am Heart J. 2000 Oct; 140(4):585-95. View Abstract
  366. Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation. 2000 Sep 26; 102(13):1542-8. View Abstract
  367. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 2000 Sep 14; 343(11):759-66. View Abstract
  368. Left atrial compression from severe aortic root dilation and scoliosis. Heart Dis. 2000 Sep-Oct; 2(5):340-1. View Abstract
  369. Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant. 2000 Aug; 19(8):756-64. View Abstract
  370. Electrocardiography and 24-hour electrocardiographic ambulatory recording (Holter monitor) studies in children infected with human immunodeficiency virus type 1. The Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV-1 Infection Study Group. Pediatr Cardiol. 2000 May-Jun; 21(3):189-96. View Abstract
  371. Reconstruction of 3-dimensional right ventricular shape and volume from 3 orthogonal planes. J Am Soc Echocardiogr. 2000 Mar; 13(3):177-85. View Abstract
  372. A new quantitative method for the diagnosis of right ventricular hypertensive disorders in 3 dimensions. J Am Soc Echocardiogr. 2000 Mar; 13(3):186-93. View Abstract
  373. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000 Feb; 139(2 Pt 1):217-23. View Abstract
  374. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000 Feb; 139(2 Pt 3):S86-95. View Abstract
  375. Echocardiographic identification of thymic hypoplasia in tetralogy of fallot/tetralogy pulmonary atresia. Am J Cardiol. 1999 Nov 15; 84(10):1268-71, A9. View Abstract
  376. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation. 1999 Nov 09; 100(19 Suppl):II187-93. View Abstract
  377. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone. J Clin Endocrinol Metab. 1999 Sep; 84(9):3099-109. View Abstract
  378. Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute. Pediatrics. 1999 Aug; 104(2):e14. View Abstract
  379. Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol. 1999 May; 33(6):1702-9. View Abstract
  380. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1999 Feb 25; 340(8):653-4; author reply 655. View Abstract
  381. Prognostic significance of clinically silent coronary artery fistulas. Am J Cardiol. 1999 Feb 01; 83(3):407-11. View Abstract
  382. Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland. J Am Coll Cardiol. 1998 Nov 15; 32(6):1749-55. View Abstract
  383. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998 Aug; 133(2):254-8. View Abstract
  384. Evaluation of regional differences in right ventricular systolic function by acoustic quantification echocardiography and cine magnetic resonance imaging. Circulation. 1998 Jul 28; 98(4):339-45. View Abstract
  385. Verapamil therapy in infants with hypertrophic cardiomyopathy. Cardiol Young. 1998 Jul; 8(3):310-9. View Abstract
  386. Utility of intraoperative transesophageal echocardiography in the assessment of residual cardiac defects. Pediatr Cardiol. 1998 Jul-Aug; 19(4):346-51. View Abstract
  387. Utility and feasibility of assessing myocardial mechanics after bypass. Crit Care Med. 1998 May; 26(5):822-4. View Abstract
  388. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation. 1998 Apr 07; 97(13):1246-56. View Abstract
  389. Development and validation of an echocardiographic model for predicting progression of discrete subaortic stenosis in children. Am J Cardiol. 1998 Feb 01; 81(3):314-20. View Abstract
  390. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998 Feb; 16(2):545-50. View Abstract
  391. Accuracy of echocardiography for detection of aortic arch obstruction after stage I Norwood procedure. Am Heart J. 1998 Feb; 135(2 Pt 1):230-6. View Abstract
  392. Automated Left Ventricular Endocardial Border Detection Using Acoustic Quantification in Children. Echocardiography. 1998 Feb; 15(2):111-120. View Abstract
  393. Left ventricular dysfunction after open repair of simple congenital heart defects in infants and children. J Thorac Cardiovasc Surg. 1998 Jan; 115(1):74-6. View Abstract
  394. Left ventricular mechanics and geometry in patients with congenital complete atrioventricular block. Circulation. 1997 Nov 18; 96(10):3430-5. View Abstract
  395. Nutritional status and cardiac mass and function in children infected with the human immunodeficiency virus. Am J Clin Nutr. 1997 Sep; 66(3):660-4. View Abstract
  396. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg. 1997 Sep; 114(3):392-403; discussion 404-5. View Abstract
  397. Anomalous origin of left coronary artery from pulmonary artery: recovery of left ventricular function after dual coronary repair. J Am Coll Cardiol. 1997 Aug; 30(2):547-53. View Abstract
  398. Mechanics of left ventricular systolic and diastolic function in physiologic hypertrophy of the athlete's heart. Cardiol Clin. 1997 Aug; 15(3):355-72. View Abstract
  399. Clinical course and hemodynamic observations after supraannular mitral valve replacement in infants and children. J Am Coll Cardiol. 1997 Apr; 29(5):1089-94. View Abstract
  400. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997 Mar; 8(3):259-70. View Abstract
  401. Transvascular balloon dilation for neonatal critical aortic stenosis: early and midterm results. J Am Coll Cardiol. 1997 Feb; 29(2):442-7. View Abstract
  402. Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):51-9. View Abstract
  403. Sevoflurane depresses myocardial contractility less than halothane during induction of anesthesia in children. Anesthesiology. 1996 Dec; 85(6):1260-7. View Abstract
  404. Outcome of patients with ectopia cordis and significant intracardiac defects. Circulation. 1996 Nov 01; 94(9 Suppl):II32-7. View Abstract
  405. Control mechanisms for physiological hypertrophy of pregnancy. Circulation. 1996 Aug 15; 94(4):667-72. View Abstract
  406. Tissue engineering lamb heart valve leaflets. Biotechnol Bioeng. 1996 Jun 05; 50(5):562-7. View Abstract
  407. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol. 1996 Jan; 19(1):42-9. View Abstract
  408. High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. J Electrocardiol. 1996; 29 Suppl:234-40. View Abstract
  409. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation. 1995 Oct 15; 92(8):2220-5. View Abstract
  410. Correction. Predictors of survival in neonates with critical aortic stenosis. Circulation. 1995 Oct 01; 92(7):2005. View Abstract
  411. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation. 1995 Sep 15; 92(6):1531-8. View Abstract
  412. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995 06 29; 332(26):1738-43. View Abstract
  413. In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol. 1995 Mar 01; 25(3):739-45. View Abstract
  414. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):303-10. View Abstract
  415. Status of the left ventricle after arterial switch operation for transposition of the great arteries. Hemodynamic and echocardiographic evaluation. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):311-21. View Abstract
  416. Echocardiographic predictors of candidacy for successful transcatheter atrial septal defect closure. Cathet Cardiovasc Diagn. 1995 Jan; 34(1):29-34. View Abstract
  417. Effect of young age on coronary adaptations to left ventricular pressure overload hypertrophy in sheep. J Am Coll Cardiol. 1994 Dec; 24(7):1786-96. View Abstract
  418. Nonlinearity of left ventricular end-systolic wall stress-velocity of fiber shortening relation. J Am Coll Cardiol. 1994 Oct; 24(4):1178-80. View Abstract
  419. Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virus. J Pediatr. 1994 Oct; 125(4):563-70. View Abstract
  420. Coronary echocardiography in 406 patients with d-loop transposition of the great arteries. J Am Coll Cardiol. 1994 Sep; 24(3):763-8. View Abstract
  421. Rapid two-stage arterial switch operation. Evaluation of left ventricular systolic mechanics late after an acute pressure overload stimulus in infancy. Circulation. 1994 Sep; 90(3):1294-303. View Abstract
  422. Rapid two-stage arterial switch operation. Acquisition of left ventricular mass after pulmonary artery banding in infants with transposition of the great arteries. Circulation. 1994 Sep; 90(3):1304-9. View Abstract
  423. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994 Sep; 90(3):1310-8. View Abstract
  424. Balloon aortic valvuloplasty in the young adult with congenital aortic stenosis. Am J Cardiol. 1994 Jun 01; 73(15):1112-7. View Abstract
  425. Induction of right ventricular hypertrophy with obstructing balloon catheter. Circulation. 1994 Apr; 89(4):1911-2. View Abstract
  426. Monitoring for anthracycline cardiotoxicity. Pediatrics. 1994 Mar; 93(3):433-7. View Abstract
  427. Myocardial perfusion, function and exercise tolerance after the arterial switch operation. J Am Coll Cardiol. 1994 Feb; 23(2):424-33. View Abstract
  428. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994 Jan; 89(1):252-7. View Abstract
  429. Echocardiographic predictors of left ventricular outflow tract obstruction after repair of interrupted aortic arch. J Am Coll Cardiol. 1993 Dec; 22(7):1953-60. View Abstract
  430. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction. Circulation. 1993 Nov; 88(5 Pt 1):2415-25. View Abstract
  431. Right ventricular decompression and left ventricular function in pulmonary atresia with intact ventricular septum. The influence of less extensive coronary anomalies. Circulation. 1993 Nov; 88(5 Pt 2):II183-8. View Abstract
  432. Reliability of Doppler color flow mapping in the identification and localization of multiple ventricular septal defects. Echocardiography. 1993 Nov; 10(6):573-81. View Abstract
  433. Multipolar endocardial mapping of the right atrium during cardiac catheterization: description of a new technique. J Am Coll Cardiol. 1993 Oct; 22(4):1105-10. View Abstract
  434. Diagnosis of intramural coronary artery in transposition of the great arteries using two-dimensional echocardiography. Circulation. 1993 Sep; 88(3):1136-41. View Abstract
  435. Growth of the aortic anastomosis, annulus, and root after the arterial switch procedure performed in infancy. Circulation. 1993 Aug; 88(2):615-20. View Abstract
  436. Individual pulmonary vein size and survival in infants with totally anomalous pulmonary venous connection. J Am Coll Cardiol. 1993 Jul; 22(1):201-6. View Abstract
  437. Conal anatomy in 119 patients with d-loop transposition of the great arteries and ventricular septal defect: an echocardiographic and pathologic study. J Am Coll Cardiol. 1993 Jun; 21(7):1712-21. View Abstract
  438. Response of the hypertrophied left ventricle to tachycardia: importance of maturation. Am J Physiol. 1993 Mar; 264(3 Pt 2):H983-93. View Abstract
  439. Second natural history study of congenital heart defects. Aortic stenosis: echocardiography. Circulation. 1993 Feb; 87(2 Suppl):I66-72. View Abstract
  440. Second natural history study of congenital heart defects. Pulmonary stenosis: echocardiography. Circulation. 1993 Feb; 87(2 Suppl):I73-9. View Abstract
  441. Second natural history study of congenital heart defects. Ventricular septal defect: echocardiography. Circulation. 1993 Feb; 87(2 Suppl):I80-8. View Abstract
  442. Natural history and patterns of recovery of contractile function in single left ventricle after Fontan operation. Circulation. 1992 Dec; 86(6):1753-61. View Abstract
  443. Course in the intensive care unit after 'preparatory' pulmonary artery banding and aortopulmonary shunt placement for transposition of the great arteries with low left ventricular pressure. Circulation. 1992 Nov; 86(5 Suppl):II133-9. View Abstract
  444. Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med. 1992 Oct 29; 327(18):1260-5. View Abstract
  445. Different responses of extent and velocity of contraction to dobutamine in conscious sheep. Am J Physiol. 1992 Oct; 263(4 Pt 2):H1250-61. View Abstract
  446. Echocardiography in the preoperative evaluation of vascular rings. J Pediatr Surg. 1992 Aug; 27(8):1118-20; discussion 1120-1. View Abstract
  447. Mechanics of left ventricular systolic and diastolic function in physiologic hypertrophy of the athlete heart. Cardiol Clin. 1992 May; 10(2):227-40. View Abstract
  448. Diagnosis of anomalous left coronary artery by Doppler color flow mapping: distinction from other causes of dilated cardiomyopathy. J Am Coll Cardiol. 1992 May; 19(6):1271-5. View Abstract
  449. Spinal fusion in Duchenne muscular dystrophy: a multidisciplinary approach. Muscle Nerve. 1992 May; 15(5):604-14. View Abstract
  450. Myocardial function in immature and mature sheep with pressure-overload hypertrophy. Am J Physiol. 1992 Apr; 262(4 Pt 2):H1036-48. View Abstract
  451. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol. 1992 Mar 01; 19(3):619-29. View Abstract
  452. Bulboventricular foramen size in infants with double-inlet left ventricle or tricuspid atresia with transposed great arteries: influence on initial palliative operation and rate of growth. J Am Coll Cardiol. 1992 Jan; 19(1):142-8. View Abstract
  453. Pulmonary valve-moderator band distance and association with development of double-chambered right ventricle. Am J Cardiol. 1991 Dec 15; 68(17):1681-6. View Abstract
  454. Cardiotoxicity during treatment of severe childhood asthma. Pediatrics. 1991 Dec; 88(6):1180-6. View Abstract
  455. Predictors of survival in neonates with critical aortic stenosis. Circulation. 1991 Dec; 84(6):2325-35. View Abstract
  456. Two-dimensional echocardiography in the pre- and postoperative management of totally anomalous pulmonary venous connection. J Am Coll Cardiol. 1991 Dec; 18(7):1746-51. View Abstract
  457. Function of the anatomic pulmonary valve in the systemic circulation. Circulation. 1991 Nov; 84(5 Suppl):III173-9. View Abstract
  458. Late potentials and their relation to ventricular function in human immunodeficiency virus infection. Am J Cardiol. 1991 Nov 01; 68(11):1216-20. View Abstract
  459. Double-inlet single left ventricle: echocardiographic anatomy with emphasis on the morphology of the atrioventricular valves and ventricular septal defect. J Am Coll Cardiol. 1991 Aug; 18(2):559-68. View Abstract
  460. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 06; 324(23):1633-9. View Abstract
  461. Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration. Circ Res. 1991 May; 68(5):1458-70. View Abstract
  462. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991 Mar 21; 324(12):808-15. View Abstract
  463. Comparison of maximal oxygen uptakes from the tethered, the 183- and 457-meter unimpeded supramaximal freestyle swims. Int J Sports Med. 1991 Feb; 12(1):6-9. View Abstract
  464. Results of the arterial switch operation in patients with transposition of the great arteries and abnormalities of the mitral valve or left ventricular outflow tract. J Am Coll Cardiol. 1990 Nov; 16(6):1446-54. View Abstract
  465. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol. 1990 Jul 15; 66(2):246-50. View Abstract
  466. Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Circulation. 1989 Dec; 80(6):1689-705. View Abstract
  467. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol. 1989 Jun 15; 63(20):1489-97. View Abstract
  468. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation. 1989 Jun; 79(6):1237-46. View Abstract
  469. Recognition of abnormal connections of coronary arteries with the use of Doppler color flow mapping. J Am Coll Cardiol. 1989 Mar 15; 13(4):922-6. View Abstract
  470. Echocardiographic and anatomic findings in atrioventricular discordance with ventriculoarterial concordance. Am J Cardiol. 1988 Dec 01; 62(17):1256-62. View Abstract
  471. Echocardiographic diagnosis of fetal heart defects in mid trimester. Arch Dis Child. 1988 Oct; 63(10 Spec No):1137-45. View Abstract
  472. Effect of isolated right ventricular outflow obstruction on left ventricular function in infants. Am J Cardiol. 1988 Oct 01; 62(10 Pt 1):778-84. View Abstract
  473. Noninvasive estimation of the left ventricular pressure waveform throughout ejection in young patients with aortic stenosis. J Am Coll Cardiol. 1988 Aug; 12(2):492-7. View Abstract
  474. Myocardial performance after arterial switch operation for transposition of the great arteries with intact ventricular septum. Circulation. 1988 Jul; 78(1):132-41. View Abstract
  475. Midterm results after the arterial switch operation for transposition of the great arteries with intact ventricular septum: clinical, hemodynamic, echocardiographic, and electrophysiologic data. Circulation. 1988 Jun; 77(6):1333-44. View Abstract
  476. Are routine preoperative cardiac catheterization and angiography necessary before repair of ostium primum atrial septal defect? J Am Coll Cardiol. 1988 Feb; 11(2):373-8. View Abstract
  477. Left ventricular mechanics in the normal newborn. Circulation. 1987 Nov; 76(5):1029-36. View Abstract
  478. Left ventricular mechanics and contractile state in children and young adults with end-stage renal disease: effect of dialysis and renal transplantation. J Am Coll Cardiol. 1987 Nov; 10(5):1085-94. View Abstract
  479. Echocardiographic identification of aortic atresia with ventricular septal defect, normal left ventricle and mitral valve. Am Heart J. 1987 Jun; 113(6):1521-3. View Abstract
  480. Physiologic hypertrophy: effects on left ventricular systolic mechanics in athletes. J Am Coll Cardiol. 1987 Apr; 9(4):776-83. View Abstract
  481. Diagnosis of coronary artery anatomy by two-dimensional echocardiography in patients with transposition of the great arteries. Circulation. 1987 Mar; 75(3):557-64. View Abstract
  482. Regional and global left ventricular function in infants with anomalous origin of the left coronary artery from the pulmonary trunk: preoperative and postoperative assessment. Circulation. 1987 Jan; 75(1):115-23. View Abstract
  483. Quantitative applications of Doppler cardiography in congenital heart disease. Cardiovasc Intervent Radiol. 1987; 10(6):332-47. View Abstract
  484. Obstruction of right ventricular inflow and outflow in corrected transposition of the great arteries (S,L,L): two-dimensional echocardiographic diagnosis. J Am Coll Cardiol. 1986 Aug; 8(2):407-11. View Abstract
  485. Two-dimensional echocardiographic anatomy in crisscross heart. Am J Cardiol. 1986 Aug 01; 58(3):325-33. View Abstract
  486. Right ventricular systolic time intervals: comparison of echocardiographic and Doppler-derived values. Am Heart J. 1986 Jul; 112(1):103-7. View Abstract
  487. Cardiac output estimates in the pediatric intensive care unit using a continuous-wave Doppler computer: validation and limitations of the technique. Am Heart J. 1986 Jul; 112(1):97-103. View Abstract
  488. Surgery for univentricular atrioventricular connection ("single ventricle") Am J Cardiol. 1986 May 01; 57(13):1212. View Abstract
  489. Global and regional right ventricular function in normal infants and infants with transposition of the great arteries after Senning operation. Circulation. 1985 Nov; 72(5):1008-14. View Abstract
  490. Altered left ventricular mechanics in patients with valvular aortic stenosis and coarction of the aorta: effects on systolic performance and late outcome. Circulation. 1985 Sep; 72(3):515-22. View Abstract
  491. Left ventricular diastolic function in elite athletes with physiologic cardiac hypertrophy. J Am Coll Cardiol. 1985 Sep; 6(3):545-9. View Abstract
  492. Prenatal diagnosis of congenital heart defects in thoracoabdominally conjoined twins. N Engl J Med. 1985 Aug 08; 313(6):370-4. View Abstract
  493. Two-dimensional echocardiographic findings in double orifice mitral valve. J Am Coll Cardiol. 1985 Aug; 6(2):383-7. View Abstract
  494. Two-dimensional echocardiographic evaluation of right ventricular size and function in newborns with severe right ventricular outflow tract obstruction. J Am Coll Cardiol. 1985 Aug; 6(2):388-93. View Abstract
  495. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med. 1985 Jun 20; 312(25):1600-3. View Abstract
  496. Use of the calibrated carotid pulse tracing for calculation of left ventricular pressure and wall stress throughout ejection. Am Heart J. 1985 Jun; 109(6):1306-10. View Abstract
  497. Early diastolic left ventricular function in children and adults with aortic stenosis. J Am Coll Cardiol. 1985 May; 5(5):1147-54. View Abstract
  498. Two-dimensional echocardiographic estimation of right ventricular area change and ejection fraction in infants with systemic right ventricle (transposition of the great arteries or hypoplastic left heart syndrome). Am J Cardiol. 1985 Apr 15; 55(9):1153-7. View Abstract
  499. Perioperative complications in patients with anthracycline chemotherapeutic agents. Can Anaesth Soc J. 1985 Mar; 32(2):149-57. View Abstract
  500. Effects of loading conditions and contractile state (methoxamine and dobutamine) on left ventricular early diastolic function in normal subjects. Am J Cardiol. 1985 Mar 01; 55(6):790-6. View Abstract
  501. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol. 1984 Oct; 4(4):715-24. View Abstract
  502. Use of the indirect axillary pulse tracing for noninvasive determination of ejection time, upstroke time, and left ventricular wall stress throughout ejection in infants and young children. Am J Cardiol. 1984 Apr 01; 53(8):1154-8. View Abstract
  503. Combined fluid-filled and micromanometer-tip catheter system for high-fidelity pressure recordings in infants. Cathet Cardiovasc Diagn. 1984; 10(6):619-23. View Abstract
  504. Incidence and significance of primary abnormalities of cardiac rhythm in infants at high risk for sudden infant death syndrome. Pediatr Cardiol. 1984; 5(4):267-71. View Abstract
  505. Effects of enhanced afterload (methoxamine) and contractile state (dobutamine) on the left ventricular late-systolic wall stress-dimension relation. Am J Cardiol. 1983 Dec 01; 52(10):1304-9. View Abstract
  506. Assessment of left ventricular contractility in patients receiving doxorubicin. Ann Intern Med. 1983 Dec; 99(6):750-6. View Abstract
  507. Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: comparison with central aortic pressure measurements. Am J Cardiol. 1983 Oct 01; 52(7):867-70. View Abstract
  508. Ventricular function before and after repair of tetralogy of Fallot. Am J Cardiol. 1983 May 15; 51(9):1568-9. View Abstract
  509. Inotropic properties of captopril. Am Heart J. 1982 Jul; 104(1):175-6. View Abstract
  510. Multifocal or chaotic atrial rhythm: report of nine infants, delineation of clinical course and management, and review of the literature. Pediatr Cardiol. 1982; 2(3):179-84. View Abstract

Contact Steven Colan

Print Profile